** MSC 2008-TOP29 **  $1.2Bn Fixed Rate CMBS

Co-Lead Bookrunners: Morgan Stanley, Bear Stearns Rating Agencies:
S&P, Fitch


Structure:
 CL SIZE($MM) S&P/FITCH  C/E     A/L  PX LEV COUPON   PRICE     YIELD
CUSIP
 A1    46.0   AAA/AAA  27.000%  3.39  S+340  6.231   99.23983  6.5199
61757LAA8
 A2    36.1   AAA/AAA  27.000%  4.76  S+250  6.115  100.54614  6.0202
61757LAB6
 A3    64.8   AAA/AAA  27.000%  6.39  S+310  6.280   97.13802  6.9826
61757LAC4
 AAB   49.2   AAA/AAA  27.000%  6.85  S+250  6.280   99.66708  6.4765
61757LAD2
 A4   629.6   AAA/AAA  27.000%  9.70  S+235  6.280   97.83208  6.7362
61757LAE0
 A4-FL 75.0   AAA/AAA  27.000%  9.70  L+211  L+211  100.00000   L+211
61757LAH3
 AM   123.4   AAA/AAA  17.000%  9.86  S+370  6.280   88.87035  8.1056
61757LAF7
*AJ1   72.5   AAA/AAA  11.125%  9.86  S+515  6.280   80.52003  9.5556
61757LAG5
*B     20.1   AA/AA     9.500%  9.86  S+590  6.280   76.60160 10.3056
61757LAL4
*C     10.8   AA-/AA-   8.625%  9.86  S+700  6.280   71.29835 11.4056
61757LAM2
*D     21.6   A/A       6.875%  9.86  S+800  6.280   66.89503 12.4056
61757LAN0
*E     12.3   A-/A-     5.875%  9.89  S+875  6.280   63.78325 13.1585
61757LAP5
*F     13.9   BBB+/BBB+ 4.750%  9.95  S+1150 6.280   53.93824 15.9156
61757LAQ3


 *  Subject to rule 144A


Details:
 - The Coupon for Classes A3 through F are Initial Only
 - Settlement: 2/29/08
 - First Payment Date: 3/13/08
 - Rated Final Distribution Date: 1/11/43




STATEMENT REGARDING FREE WRITING PROSPECTUS

The depositor has filed a registration statement (including a
prospectus) with the SEC for the offering to which this free writing prospectus
relates. Before you invest, you should read the prospectus in the registration
statement and other documents the depositor has filed with the SEC for more
complete information about the depositor, the issuer and this offering. You may
get these documents for free by visiting EDGAR on the SEC Web site at
www.sec.gov. Alternatively, the depositor, any underwriter or any dealer
participating in the offering will arrange to send you the prospectus; you
request it by calling toll free 1-866-718-1649 or by email at
prospectus@morganstanley.com.

This free writing prospectus does not contain all information that is required
to be included in the base prospectus and the prospectus supplement.

The Information in this free writing prospectus is preliminary and is subject to
completion or change.

The Information in this free writing prospectus supersedes information contained
in any prior similar free writing prospectus relating to these securities prior
to the time of your commitment to purchase.

This free writing prospectus is not an offer to sell or solicitation of an offer
to buy these securities in any state where such offer, solicitation or sale is
not permitted.


IMPORTANT NOTICE RELATING TO AUTOMATICALLY GENERATED EMAIL DISCLAIMERS

Any legends, disclaimers or other notices that may appear at the bottom of, or
attached to, this communication relating to:

(1) these materials not constituting an offer (or a solicitation of an offer),

(2) no representation that these materials are accurate or complete and may not
be updated, or

(3) these materials possibly being confidential,

are not applicable to these materials and should be disregarded. Such legends,
disclaimers or other notices have been automatically generated as a result of
these materials having been sent via Bloomberg or another system.
--------------------------------------------------------------------------------

This is not an offer (or solicitation of an offer) to buy/sell the
securities/instruments mentioned or an official confirmation. Morgan Stanley may
deal as principal in or own or act as market maker for securities/instruments
mentioned or may advise the issuers. This is not research and is not from MS
Research but it may refer to a research analyst/research report. Unless
indicated, these views are the author's and may differ from those of Morgan
Stanley research or others in the Firm. We do not represent this is accurate or
complete and we may not update this. Past performance is not indicative of
future returns. For additional information, research reports and important
disclosures, contact me or see https://secure.ms.com/servlet/cls. You should not
use e-mail to request, authorize or effect the purchase or sale of any security
or instrument, to send transfer instructions, or to effect any other
transactions. We cannot guarantee that any such requests received via e-mail
will be processed in a timely manner. This communication is solely for the
addressee(s) and may contain confidential information.
We do not waive confidentiality by mistransmission. Contact me if you do not
wish to receive these communications. In the UK, this communication is directed
in the UK to those persons who are professional and eligible counterparties (as
defined in the UK Financial Services Authority's rules).